Academic Journal
48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors
العنوان: | 48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors |
---|---|
المؤلفون: | Park, J-C., Baranda, J.C., Mita, M.M., Iams, W.T., Gordon, M.S., Taylor, M., Dhani, N., Loughhead, S.M., Ji, R-R., Zwirtes, R.F., Kornacker, M., Rosen, O., Bernstein, H., Jimeno, A. |
المصدر: | Annals of Oncology ; volume 32, page S1393 ; ISSN 0923-7534 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.annonc.2021.10.065 |
الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2021.10.065 https://api.elsevier.com/content/article/PII:S0923753421046019?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753421046019?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
رقم الانضمام: | edsbas.9C75E5C1 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.annonc.2021.10.065 |
---|